Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches in managing bipolar depression.

Paul E Keck1, Susan L McElroy

  • 1Program Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0559, USA. paul.keck@uc.edu

The Journal of Clinical Psychiatry
|March 11, 2003
PubMed
Summary

Pharmacologic treatment for bipolar depression is improving with new medications and combination therapies. Research reviews randomized trials and naturalistic studies on mood stabilizers and antidepressants for acute and long-term care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants.

Focus (American Psychiatric Publishing)·2024
Same author

Are personality disorders in bipolar patients more frequent in the US than Europe?

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2022
Same author

Comparison of Demographic and Clinical Features of Bipolar Disorder in Persons of African and European Ancestry.

Journal of racial and ethnic health disparities·2022
Same author

Characterisation of age and polarity at onset in bipolar disorder.

The British journal of psychiatry : the journal of mental science·2022
Same author

Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response.

Journal of affective disorders·2021
Same author

Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors.

Biological psychiatry·2021

Area of Science:

  • Psychiatry and Pharmacology
  • Mood Disorders Research

Background:

  • Pharmacologic treatment for bipolar depression historically lacked robust study.
  • Emerging data highlight new medications and combination therapies.

Purpose of the Study:

  • To review current evidence on pharmacologic treatments for bipolar depression.
  • To assess efficacy of new agents and combination therapies.
  • To examine risks associated with antidepressant use in bipolar depression.

Main Methods:

  • Review of randomized controlled trials (RCTs) for mood stabilizers and antidepressants.
  • Analysis of naturalistic studies on treatment outcomes.
  • Examination of risks for mood switching and depressive relapse.

Main Results:

Related Experiment Videos

  • New data indicate improved efficacy of certain medications and combination treatments.
  • Antidepressant use in bipolar depression carries risks of mood switching and relapse.
  • Evidence for long-term treatment efficacy is still developing.

Conclusions:

  • Current research supports the use of specific mood stabilizers and antidepressants for bipolar depression.
  • Careful monitoring is crucial to mitigate risks associated with antidepressant therapy.
  • Further research is needed to optimize long-term management strategies.